Ponatinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ponatinib
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Ponatinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 3 USDMF, 3 EU WC, 4 NDC API, 10 Listed Suppliers, $ API Reference Price

15 API Suppliers
3 USDMF
3 EU WC
4 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

23 FDF Dossiers, 6 FDA Orange Book, 10 Europe, 1 Canada, 6 Australia

23 FDF Dossiers
6 FDA Orange Book
10 Europe
1 Canada
6 Australia

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 45MG BASE

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 15MG BASE
TABLET;ORAL - EQ 30MG BASE
TABLET;ORAL - EQ 45MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 10 Kerry, 1 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures
10 Kerry
1 Keval Exports
9 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Pharmatrans-Sanaq
2 Pluviaendo
2 Prachin Chemical
7 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
8 Sigachi Industries
2 Silverline Chemicals
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Fillers, Diluents & Binders, 12 Direct Compression, 11 Granulation, 10 Lubricants & Glidants, 9 Thickeners and Stabilizers, 8 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 3 Controlled & Modified Release, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Coating Systems & Additives, 2 Taste Masking, 1 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Rheology Modifiers, 1 Parenteral

27 Fillers, Diluents & Binders
12 Direct Compression
11 Granulation
10 Lubricants & Glidants
9 Thickeners and Stabilizers
8 Co-Processed Excipients
4 Disintegrants & Superdisintegrants
3 Controlled & Modified Release
3 Emulsifying Agents
3 Chewable & Orodispersible Aids
2 Coating Systems & Additives
2 Taste Masking
1 Film Formers & Plasticizers
1 API Stability Enhancers
1 Rheology Modifiers
1 Parenteral

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 39 News #PharmaBuzz

1 Stock Recap #PipelineProspector
39 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 7 Regulatory FDF Prices, 10 Annual Reports

1 US Medicaid Prescriptions
7 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

68 US Patents, 8 US Exclusivities, 4 Health Canada Patents

68 US Patents
8 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 84,358 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling WLG

filter Patent Reset all filters

4 All

01 22634923

02 22815506

filter Product Reset all filters

4 All

01 4PONATINIB HYDROCHLORIDE

filter Dosage Reset all filters

4 All

01 4TABLET

filter Exp Date Reset all filters

4 All

01 22026-12-22

02 22033-05-09

Product Main Page

01

Gowling WLG

PONATINIB HYDROCHLORIDE

Formnext Forum

Not Confirmed

Gowling WLG

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-22

Date Granted : 2015-05-05

PONATINIB HYDROCHLORIDE

Brand Name : ICLUSIG

Patent Number : 2634923

Filing Date : 2006-12-22

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-12-22

Date Granted : 2015-05-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG

PONATINIB HYDROCHLORIDE

Formnext Forum

Not Confirmed

Gowling WLG

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-22

Date Granted : 2015-05-05

PONATINIB HYDROCHLORIDE

Brand Name : ICLUSIG

Patent Number : 2634923

Filing Date : 2006-12-22

Strength per Unit : 45 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-12-22

Date Granted : 2015-05-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG

PONATINIB HYDROCHLORIDE

Formnext Forum

Not Confirmed

Gowling WLG

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-09

Date Granted : 2018-12-11

PONATINIB HYDROCHLORIDE

Brand Name : ICLUSIG

Patent Number : 2815506

Filing Date : 2013-05-09

Strength per Unit : 15 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-05-09

Date Granted : 2018-12-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG

PONATINIB HYDROCHLORIDE

Formnext Forum

Not Confirmed

Gowling WLG

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-09

Date Granted : 2018-12-11

PONATINIB HYDROCHLORIDE

Brand Name : ICLUSIG

Patent Number : 2815506

Filing Date : 2013-05-09

Strength per Unit : 45 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-05-09

Date Granted : 2018-12-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!